In this section of cadth.ca, drug manufacturers and publicly funded drug plans can find the documentation and resources needed to file a drug submission application to the CADTH Common Drug Review (CDR) and to manage the review process that follows.
There are also resources available for keeping current:
- Learn about changes to submission requirements and new initiatives by subscribing to CDR Update.
- Track the status of specific drug reviews and find out about Canadian Drug Expert Committee (CDEC) recommendations by using the new, more powerful cadth.ca search engine. Status information on drug review listings is usually posted on cadth.ca every Friday, reflecting activity to Thursday noon. Recommendations are posted as they are finalized.
If you represent a patient group or other stakeholder wishing to provide input into the CADTH CDR process, please refer to the section of cadth.ca created for that purpose. General information about the CDR is available in the About section.